Functions of MDMX in the modulation of the p53-response

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Jochemsen, Aart G ^a   Lenos, Kristiaan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; LEPTOMYCIN B; MESSENGER RNA; PROTEIN MDMX; PROTEIN P53; TRANSCRIPTION ELONGATION FACTOR; UBIQUITIN; PROTEIN MDM2;

ALTERNATIVE RNA SPLICING; APOPTOSIS; CELLULAR STRESS RESPONSE; DNA DAMAGE; DOWN REGULATION; GENOTOXICITY; HUMAN; LETHAL DOSE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; RIBOSOMAL FRAMESHIFTING; RIBOSOME; RNA SPLICING; STRESS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; DNA DAMAGE; HUMANS; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959336105     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/876173     Document Type: Review

References (92)

1. Zuckerman V., Wolyniec K., Sionov R. V., Haupt S., Haupt Y., Tumour suppression by p53: the importance of apoptosis and cellular senescence Journal of Pathology 2009 219 1 3 15
2. Helton E. S., Chen X., p53 modulation of the DNA damage response Journal of Cellular Biochemistry 2007 100 4 883 896
3. Teodoro J. G., Evans S. K., Green M. R., Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome Journal of Molecular Medicine 2007 85 11 1175 1186 (Pubitemid 47622219)
4. Gottlieb E., Vousden K. H., p53 regulation of metabolic pathways Cold Spring Harbor Perspectives in Biology 2010 2 4
5. Pan Y., Chen J., Modification of MDMX by sumoylation Biochemical and Biophysical Research Communications 2005 332 3 702 709 (Pubitemid 40745171)
6. Chen L., Li C., Pan Y., Chen J., Regulation of p53-MDMX interaction by casein kinase 1 alpha Molecular and Cellular Biology 2005 25 15 6509 6520 (Pubitemid 41023226)
7. Elias B., Laine A., Ronai Z., Phosphorylation of MdmX by CDK2/Cdc2 is required for nuclear export of Mdm2 Oncogene 2005 24 15 2574 2579 (Pubitemid 40593048)
8. Wang Y. V., Wade M., Wahl G. M., Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo Cell Cycle 2009 8 21 3443 3444
9. Wade M., Wang Y. V., Wahl G. M., The p53 orchestra: Mdm2 and Mdmx set the tone Trends in Cell Biology 2010 20 5 299 309
10. Marine J. C., Lozano G., Mdm2-mediated ubiquitylation: p53 and beyond Cell Death and Differentiation 2010 17 1 93 102
11. Bttger V., Bttger A., Garcia-Echeverria C., Ramos Y. F. M., van der Eb A. J., Jochemsen A. G., Lane D. P., Comparative study of the p53-mdm2 and p53-MDMX interfaces Oncogene 1999 18 1 189 199 (Pubitemid 29060593)
12. Sharp D. A., Kratowicz S. A., Sank M. J., George D. L., Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein The Journal of Biological Chemistry 1999 274 53 38189 38196 (Pubitemid 30026893)
13. Kawai H., Wiederschain D., Yuan Z. M., Critical contribution of the MDM2 acidic domain to p53 ubiquitination Molecular and Cellular Biology 2003 23 14 4939 4947 (Pubitemid 36793339)
14. Meulmeester E., Frenk R., Stad R., de Graaf P., Marine J. C., Vousden K. H., Jochemsen A. G., Critical role for a central part of Mdm2 in the ubiquitylation of p53 Molecular and Cellular Biology 2003 23 14 4929 4938 (Pubitemid 36793338)
15. Marchenko N. D., Wolff S., Erster S., Becker K., Moll U. M., Monoubiquitylation promotes mitochondrial p53 translocation The EMBO Journal 2007 26 4 923 934
16. Shi D., Pop M. S., Kulikov R., Love I. M., Kung A., Grossman S. R., CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53 Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16275 16280
17. Lee J. T., Gu W., The multiple levels of regulation by p53 ubiquitination Cell Death and Differentiation 2010 17 1 86 92
18. Shvarts A., Steegenga W. T., Riteco N., van Laar T., Dekker P., Bazuine M., van Ham R. C. A., van der Houven van Oordt W., Hateboer G., van der Eb A. J., Jochemsen A. G., MDMX: a novel p53-binding protein with some functional properties of MDM2 The EMBO Journal 1996 15 19 5349 5357 (Pubitemid 26336217)
19. Sabbatini P., Mccormick F., MDMX inhibits the p300/CBP-mediated acetylation of p53 DNA and Cell Biology 2002 21 7 519 525
20. Danovi D., Meulmeester E., Pasini D., Migliorini D., Capra M., Frenk R., de Graaf P., Francoz S., Gasparini P., Gobbi A., Helin K., Pelicci P. G., Jochemsen A. G., Marine J. C., Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity Molecular and Cellular Biology 2004 24 13 5835 5843 (Pubitemid 38787968)
21. Krummel K. A., Lee C. J., Toledo F., Wahl G. M., The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10188 10193 (Pubitemid 41023347)
22. Gu J., Kawai H., Nie L., Kitao H., Wiederschain D., Jochemsen A. G., Parant J., Lozano G., Yuan Z. M., Mutual dependence of MDM2 and MDMX in their functional inactivation of p53 The Journal of Biological Chemistry 2002 277 22 19251 19254 (Pubitemid 34967428)
23. Kawai H., Lopez-Pajares V., Kim M. M., Wiederschain D., Yuan Z. M., RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity Cancer Research 2007 67 13 6026 6030 (Pubitemid 47037481)
24. Linke K., Mace P. D., Smith C. A., Vaux D. L., Silke J., Day C. L., Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans Cell Death and Differentiation 2008 15 5 841 848 (Pubitemid 351524426)
25. Poyurovsky M. V., Priest C., Kentsis A., Borden K. L. B., Pan Z. Q., Pavletich N., Prives C., The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity The EMBO Journal 2007 26 1 90 101 (Pubitemid 46094702)
26. Jackson M. W., Berberich S. J., Constitutive mdmx expression during cell growth, differentiation, and DNA damage DNA and Cell Biology 1999 18 9 693 700 (Pubitemid 29439221)
27. Li C., Chen L., Chen J., DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms Molecular and Cellular Biology 2002 22 21 7562 7571
28. Gentiletti F., Mancini F., D'Angelo M., Sacchi A., Pontecorvi A., Jochemsen A. G., Moretti F., MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts Oncogene 2002 21 6 867 877 (Pubitemid 34146300)
29. Pan Y., Chen J., MDM2 promotes ubiquitination and degradation of MDMX Molecular and Cellular Biology 2003 23 15 5113 5121 (Pubitemid 36950868)
30. de Graaf P., Little N. A., Ramos Y. F. M., Meulmeester E., Letteboer S. J. F., Jochemsen A. G., Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2 The Journal of Biological Chemistry 2003 278 40 38315 38324 (Pubitemid 37221723)
31. Kawai H., Wiederschain D., Kitao H., Stuart J., Tsai K. K. C., Yuan Z. M., DNA damage-induced MDMX degradation is mediated by MDM2 The Journal of Biological Chemistry 2003 278 46 45946 45953 (Pubitemid 37432741)
32. Chen L., Gilkes D. M., Pan Y., Lane W. S., Chen J., ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage The EMBO Journal 2005 24 19 3411 3422 (Pubitemid 41486779)
33. Pereg Y., Shkedy D., de Graaf P., Meulmeester E., Edelson-Averbukh M., Salek M., Biton S., Teunisse A. F. A. S., Lehmann W. D., Jochemsen A. G., Shiloh Y., Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5056 5061
34. Okamoto K., Kashima K., Pereg Y., Ishida M., Yamazaki S., Nota A., Teunisse A., Migliorini D., Kitabayashi I., Marine J. C., Prives C., Shiloh Y., Jochemsen A. G., Taya Y., DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation Molecular and Cellular Biology 2005 25 21 9608 9620 (Pubitemid 41507859)
35. Pereg Y., Lam S., Teunisse A., Biton S., Meulmeester E., Mittelman L., Buscemi G., Okamoto K., Taya Y., Shiloh Y., Jochemsen A. G., Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage Molecular and Cellular Biology 2006 26 18 6819 6831 (Pubitemid 44387632)
36. LeBron C., Chen L., Gilkes D. M., Chen J., Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3 The EMBO Journal 2006 25 6 1196 1206
37. Meulmeester E., Maurice M. M., Boutell C., Teunisse A. F. A. S., Ovaa H., Abraham T. E., Dirks R. W., Jochemsen A. G., Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2 Molecular Cell 2005 18 5 565 576 (Pubitemid 40726233)
38. Sarkari F., La Delfa A., Arrowsmith C. H., Frappier L., Sheng Y., Saridakis V., Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7 Journal of Molecular Biology 2010 402 5 825 837
39. Wood N. T., Meek D. W., MacKintosh C., 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2potential interplay with the PKB/Akt pathway and p14 FEBS Letters 2009 583 4 615 620
40. Yang W., Dicker D. T., Chen J., El-Deiry W. S., CARPs enhance p53 turnover by degrading 14-3-3 and stabilizing MDM2 Cell Cycle 2008 7 5 670 682 (Pubitemid 351499007)
41. Stommel J. M., Wahl G. M., Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation The EMBO Journal 2004 23 7 1547 1556 (Pubitemid 38579515)
42. Jin Y., Dai M. S., Lu S. Z., Xu Y., Luo Z., Zhao Y., Lu H., 14-3-3 binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation The EMBO Journal 2006 25 6 1207 1218
43. Wang Y. V., Leblanc M., Wade M., Jochemsen A. G., Wahl G. M., Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases Cancer Cell 2009 16 1 33 43
44. Zuckerman V., Lenos K., Popowicz G. M., Silberman I., Grossman T., Marine J. C., Holak T. A., Jochemsen A. G., Haupt Y., c-Abl phosphorylates Hdmx and regulates its interaction with p53 The Journal of Biological Chemistry 2009 284 6 4031 4039
45. Bartel F., Taubert H., Harris L. C., Alternative and aberrant splicing of MDM2 mRNA in human cancer Cancer Cell 2002 2 1 9 15 (Pubitemid 41043984)
46. Mancini F., Di Conza G., Moretti F., MDM4 (MDMX) and its transcript variants Current Genomics 2009 10 1 42 50
47. Chandler D. S., Singh R. K., Caldwell L. C., Bitler J. L., Lozano G., Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4 Cancer Research 2006 66 19 9502 9508 (Pubitemid 44623648)
48. Rallapalli R., Strachan G., Cho B., Mercer W. E., Hall D. J., A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity The Journal of Biological Chemistry 1999 274 12 8299 8308
49. Rallapalli R., Strachan G., Tuan R. S., Hall D. J., Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells Journal of Cellular Biochemistry 2003 89 3 563 575 (Pubitemid 36648778)
50. van der Houven van Oordt W., Diaz-Meco M. T., Lozano J., Krainer A. R., Moscat J., Cceres J. F., The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation Journal of Cell Biology 2000 149 2 307 316 (Pubitemid 30227149)
51. Shomron N., Alberstein M., Reznik M., Ast G., Stress alters the subcellular distribution of hSlu7 and thus modulates alternative splicing Journal of Cell Science 2005 118 6 1151 1159 (Pubitemid 40528686)
52. Muoz M. J., Santangelo M. S. P., Paronetto M. P., de la Mata M., Pelisch F., Boireau S., Glover-Cutter K., Ben-Dov C., Blaustein M., Lozano J. J., Bird G., Bentley D., Bertrand E., Kornblihtt A. R., DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation Cell 2009 137 4 708 720
53. Mancini F., Di Conza G., Pellegrino M., Rinaldo C., Prodosmo A., Giglio S., D'Agnano I., Florenzano F., Felicioni L., Buttitta F., Marchetti A., Sacchi A., Pontecorvi A., Soddu S., Moretti F., MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway The EMBO Journal 2009 28 13 1926 1939
54. Markey M., Berberich S. J., Full-length hdmX transcripts decrease following genotoxic stress Oncogene 2008 27 52 6657 6666
55. Chang T. C., Wentzel E. A., Kent O. A., Ramachandran K., Mullendore M., Lee K., Feldmann G., Yamakuchi M., Ferlito M., Lowenstein C. J., Arking D., Beer M. A., Maitra A., Mendell J. T., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis Molecular Cell 2007 26 5 745 752 (Pubitemid 46856245)
56. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M., Transcriptional activation of miR-34a contributes to p53-mediated apoptosis Molecular Cell 2007 26 5 731 743 (Pubitemid 46856247)
57. Mancini F., Gentiletti F., D'Angelo M., Giglio S., Nanni S., D'Angelo C., Farsetti A., Citro G., Sacchi A., Pontecorvi A., Moretti F., MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis The Journal of Biological Chemistry 2004 279 9 8169 8180 (Pubitemid 38294708)
58. Bunz F., Hwang P. M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K. W., Vogelstein B., Disruption of p53 in human cancer cells alters the responses to therapeutic agents Journal of Clinical Investigation 1999 104 3 263 269
59. Perry M. E., Piette J., Zawadzki J. A., Harvey D., Levine A. J., The mdm-2 gene is induced in response to UV light in a p53-dependent manner Proceedings of the National Academy of Sciences of the United States of America 1993 90 24 11623 11627 (Pubitemid 24008691)
60. Ashcroft M., Taya Y., Vousden K. H., Stress signals utilize multiple pathways to stabilize p53 Molecular and Cellular Biology 2000 20 9 3224 3233 (Pubitemid 30215034)
61. Wang Y., Debatin K. M., Hug H., HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels BMC Molecular Biology 2001 2, article 8
62. Di Stefano V., Blandino G., Sacchi A., Soddu S., D'Orazi G., HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function Oncogene 2004 23 30 5185 5192 (Pubitemid 38980351)
63. Batista L. F. Z., Roos W. P., Kaina B., Menck C. F. M., p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal Molecular Cancer Research 2009 7 2 237 246
64. Debernardis D., Sir E. G., de Feudis P., Vikhanskaya F., Valenti M., Russo P., Parodi S., D'Incalci M., Broggini M., p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel Cancer Research 1997 57 5 870 874 (Pubitemid 27098011)
65. Shankar E., Basu C., Adkins B., Siede W., Basu A., NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner Journal of Molecular Signaling 2010 5, article 4
66. Rubbi C. P., Milner J., Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses The EMBO Journal 2003 22 22 6068 6077 (Pubitemid 37463250)
67. Deisenroth C., Zhang Y., Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway Oncogene 2010 29 4253 4260
68. Zhang Y., Lu H., Signaling to p53: ribosomal proteins find their way Cancer Cell 2009 16 5 369 377
69. Gilkes D. M., Chen L., Chen J., MDMX regulation of p53 response to ribosomal stress The EMBO Journal 2006 25 23 5614 5625 (Pubitemid 44847201)
70. Thant A. A., Wu Y., Lee J., Mishra D. K., Garcia H., Koeffler H. P., Vadgama J. V., Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells Anticancer Research 2008 28 6 A 3579 3592
71. Lam S., Lodder K., Teunisse A. F. A. S., Rabelink M. J. W. E., Schutte M., Jochemsen A. G., Role of Mdm4 in drug sensitivity of breast cancer cells Oncogene 2010 29 16 2415 2426
72. Derenzini M., Brighenti E., Donati G., Vici M., Ceccarelli C., Santini D., Taffurelli M., Montanaro L., Trer D., The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein Journal of Pathology 2009 219 3 373 382
73. Zhu Y., Poyurovsky M. V., Li Y., Biderman L., Stahl J., Jacq X., Prives C., Ribosomal protein S7 is both a regulator and a substrate of MDM2 Molecular Cell 2009 35 3 316 326
74. Giglio S., Mancini F., Gentiletti F., Sparaco G., Felicioni L., Barassi F., Martella C., Prodosmo A., Iacovelli S., Buttitta F., Farsetti A., Soddu S., Marchetti A., Sacchi A., Pontecorvi A., Moretti F., Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization Cancer Research 2005 65 21 9687 9694 (Pubitemid 41541444)
75. Stad R., Ramos Y. F. M., Little N., Grivell S., Attema J., van der Eb A. J., Jochemsen A. G., Hdmx stabilizes Mdm2 and p53 The Journal of Biological Chemistry 2000 275 36 28039 28044
76. Moretti F., Nanni S., Farsetti A., Narducci M., Crescenzi M., Giuliacci S., Sacchi A., Pontecorvi A., Effects of exogenous p53 transduction in thyroid tumor cells with different p53 status Journal of Clinical Endocrinology and Metabolism 2000 85 1 302 308 (Pubitemid 32268830)
77. Riemenschneider M. J., Bschges R., Wolter M., Reifenberger J., Bostrm J., Kraus J. A., Schlegel U., Reifenberger G., Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification Cancer Research 1999 59 24 6091 6096 (Pubitemid 30035626)
78. Bartel F., Schulz J., Bhnke A., Blmke K., Kappler M., Bache M., Schmidt H., Wrl P., Taubert H., Hauptmann S., Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis International Journal of Cancer 2005 117 3 469 475 (Pubitemid 41429571)
79. Prodosmo A., Giglio S., Moretti S., Mancini F., Barbi F., Avenia N., Di Conza G., Schnemann H. J., Pistola L., Ludovini V., Sacchi A., Pontecorvi A., Puxeddu E., Moretti F., Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties Journal of Molecular Medicine 2008 86 5 585 596
80. Jin G., Cook S., Cui B., Chen W. C., Keir S. T., Killela P., Di C., Payne C. A., Gregory S. G., McLendon R., Bigner D. D., Yan H., HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea Neuro-Oncology 2010 12 9 956 966
81. Bo M. D., Secchiero P., Degan M., Marconi D., Bomben R., Pozzato G., Gaidano G., Del Poeta G., Forconi F., Zauli G., Gattei V., MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53 CLL with a poor cytotoxic response to Nutlin-3 British Journal of Haematology 2010 150 2 237 239
82. Valentin-Vega Y. A., Barboza J. A., Chau G. P., El-Naggar A. K., Lozano G., High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas Human Pathology 2007 38 10 1553 1562 (Pubitemid 47418967)
83. Han X., Garcia-Manero G., McDonnell T. J., Lozano G., Medeiros L. J., Xiao L., Rosner G., Nguyen M., Fernandez M., Valentin-Vega Y. A., Barboza J., Jones D. M., Rassidakis G. Z., Kantarjian H. M., Bueso-Ramos C. E., HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target Modern Pathology 2007 20 1 54 62 (Pubitemid 44967950)
84. Steinman H. A., Sluss H. K., Sands A. T., Pihan G., Jones S. N., Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth Oncogene 2004 23 1 303 306 (Pubitemid 38142265)
85. Matijasevic Z., Steinman H. A., Hoover K., Jones S. N., MDMX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice Molecular and Cellular Biology 2008 28 4 1265 1273 (Pubitemid 351214129)
86. Xiong S., Pant V., Suh Y.-A., van Pelt C. S., Wang Y., Valentin-Vega Y. A., Post S. M., Lozano G., Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4 Cancer Research 2010 70 18 7148 7154
87. de Clercq S., Gembarska A., Denecker G., Maetens M., Naessens M., Haigh K., Haigh J. J., Marine J.-C., Widespread overexpression of epitope-tagged Mdm4 does not accelerate tumor formation in vivo Molecular and Cellular Biology 2010 30 22 5394 5405
88. Gilkes D. M., Pan Y., Coppola D., Yeatman T., Reuther G. W., Chen J., Regulation of MDMX expression by mitogenic signaling Molecular and Cellular Biology 2008 28 6 1999 2010 (Pubitemid 351342630)
89. Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M., McCormick F., Opposing effects of RAS on p53: transcriptional activation of mdm2 and induction of p19(ARF) Cell 2000 103 2 321 330
90. Wei C. L., Wu Q., Vega V. B., Chiu K. P., Ng P., Zhang T., Shahab A., Yong H. C., Fu Y., Weng Z., Liu J., Zhao X. D., Chew J. L., Lee Y. L., Kuznetsov V. A., Sung W. K., Miller L. D., Lim B., Liu E. T., Yu Q., Ng H. H., Ruan Y., A global map of p53 transcription-factor binding sites in the human genome Cell 2006 124 1 207 219 (Pubitemid 43069320)
91. Li B., Cheng Q., Li Z., Chen J., p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors Cell Cycle 2010 9 7 1411 1420
92. Phillips A., Teunisse A., Lam S., Lodder K., Darley M., Emaduddin M., Wolf A., Richter J., de Lange J., Vries M. V.-D., Lenos K., Bhnke A., Bartel F., Blaydes J. P., Jochemsen A. G., HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity The Journal of Biological Chemistry 2010 285 38 29111 29127